This inventor holds 1 USPTO granted patent. Top assignee: Asclepiumm Taiwan Co., Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Pei-yi Lee and Antibody Fusion Protein Innovation.
Introduction
Pei-yi Lee is an inventor based in Taipei, Taiwan. Her patent work focuses on antibody fusion proteins designed to support the delivery of drugs across biological barriers.
Latest Patents
Lee is associated with one patent, titled “Desmoglein 2 Antibody Fusion Proteins for Drug Delivery.” The invention describes antibody fusion proteins that can act as peptide penetration systems, binding specifically to targets and helping deliver effector peptides across biological barriers for intracellular and intranuclear drug delivery. The patent record lists 1 patent.
Career Highlights
Lee is associated with Asclepiumm Taiwan Co., Ltd. Her patent reflects work on targeted delivery approaches that combine antibody binding with peptide transport.
Collaborations
Lee’s listed coworkers include Ya-ping Tsai and Chun-wei Chen.
Conclusion
Pei-yi Lee’s patent work in Taipei centers on antibody fusion proteins and their potential to enable targeted drug delivery across biological barriers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile